EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Calcium‐Sensing Receptor Suppresses Malignant Behaviours of Human Hepatocellular Carcinoma

Tingting Liu, Wei Xu, Qianqian Gao, N Ngwa Adeline iD, Qi Yang, Dawei He, Yukai Tao, Jun Sun, Jie Gu iD, Haifeng Shi, Michael Aschner iD, Yang Ye und 2 weitere

Journal of Cellular and Molecular Medicine · 2026

DOI: 10.1111/jcmm.71389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Tingting Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science and Technology Talents, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China. Hauptthemen laut MEDLINE: Receptors, Calcium-Sensing, Carcinoma, Hepatocellular, Liver Neoplasms, Naphthalenes. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kunshan Key R&D Program (Social Development), Kunshan First People's Hospital Health and Medical Technology Innovation Special Project, the Natural Science Foundation of NJUCM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) continues to pose significant worldwide health burdens due to restricted treatment alternatives and unfavourable prognosis. This investigation reveals the pivotal involvement of calcium‐sensing receptor (CaSR) in HCC advancement and its potential as a promising therapeutic target. Through pharmacological blockade with NPS‐2143 and genetic knockdown using siRNA, we found that CaSR inhibition substantially reduced HCC cell proliferation, migration, and invasion, while promoting apoptotic cell death in HepG2 and SMMC‐7721 cells. At the molecular level, CaSR interference triggered p38 MAPK activation, while inhibiting the ERK1/2 cascade, resulting in diminished expression of proliferation indicators (PCNA), metastatic markers (MMP‐2/9), and cell survival proteins (Bcl‐2), concurrent with elevated levels of apoptosis mediators (Bax, cleaved caspase‐3). In vivo, NPS‐2143 significantly suppressed xenograft tumour growth. Western blotting of xenograft tumour tissues further showed increased p‐p38/p38 and Bax levels and decreased p‐ERK/ERK, MMP‐9, and Bcl‐2 levels, consistent with the in vitro findings. Additional validation in a male nude mouse xenograft model using Huh7 cells further supported the anti‐tumour effect of NPS‐2143 in another independent HCC model. These findings suggest that CaSR facilitates malignant HCC cebehaviours through MAPK signalling and may represent a potential therapeutic target for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Calcium-SensingCarcinoma, HepatocellularLiver NeoplasmsNaphthalenesHumansAnimalsCell ProliferationApoptosisCell MovementXenograft Model Antitumor AssaysCell Line, TumorMaleMice, NudeMiceHep G2 Cellsp38 Mitogen-Activated Protein KinasesGene Expression Regulation, NeoplasticMAP Kinase Signaling SystemMatrix Metalloproteinase 9

Stichwörter der Autor:innen

MAPK signallingcalcium‐sensing receptorhepatocellular carcinomamigrationproliferation

Substanzen

Receptors, Calcium-SensingNaphthalenesp38 Mitogen-Activated Protein KinasesMatrix Metalloproteinase 9CASR protein, human

Autor:innen und Institutionen

  • Department of Science and Technology Talents, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China.
  • Department of Preventive Medicine and Public Health Laboratory Sciences, School of Basic Medicine and Public Health, Jiangsu University, Zhenjiang, Jiangsu, China.
  • Department of Pathology, Yancheng Hospital of Traditional Chinese Medicine, Yancheng, Jiangsu, China.
  • Department of Laboratory Medicine, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China.
  • Department of Pathology, Zhenjiang Hospital of Chinese Traditional and Western Medicine, Zhenjiang, Jiangsu, China.
  • Center for Experimental Research, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, China.

ORCID-Profile: N Ngwa Adeline, Jie Gu, Michael Aschner, Rongzhu Lu

Förderung

  • Kunshan Key R&D Program (Social Development)
  • Kunshan First People's Hospital Health and Medical Technology Innovation Special Project
  • the Natural Science Foundation of NJUCM
  • scientifc research project of Jiangsu Provincial Health Commission
  • Science and Technology Program of Suzhou
  • Nantong University Clinical Medicine Special Support Project

Zitieren

APA

Liu, T., Xu, W., Gao, Q., Ngwa Adeline, N., Yang, Q., He, D., Tao, Y., Sun, J., Gu, J., Shi, H., Aschner, M., Ye, Y., Chen, J., & Lu, R. (2026). Inhibition of Calcium‐Sensing Receptor Suppresses Malignant Behaviours of Human Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71389

Vancouver

Liu T, Xu W, Gao Q, Ngwa Adeline N, Yang Q, He D, et al. Inhibition of Calcium‐Sensing Receptor Suppresses Malignant Behaviours of Human Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71389

BibTeX
@article{Liu2026,
  author = {Liu, Tingting and Xu, Wei and Gao, Qianqian and Ngwa Adeline, N and Yang, Qi and He, Dawei and Tao, Yukai and Sun, Jun and Gu, Jie and Shi, Haifeng and Aschner, Michael and Ye, Yang and Chen, Jian and Lu, Rongzhu},
  title = {Inhibition of Calcium‐Sensing Receptor Suppresses Malignant Behaviours of Human Hepatocellular Carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  doi = {10.1111/jcmm.71389}
}
Kostenlos starten →